EUVIMEDEUVIMED entdecken
Crossref

Proliferative and transcriptomic response of experimental B16-F10 melanoma to modulation of murine microbiota by oral administration of Lacticaseibacillus rhamnosus K32 and Bifidobacterium adolescentis 150

Evgenii I. Olekhnovich, Alexandra A. Strokach, Vera A. Kanaeva, Maxim D. Morozov, Vladimir A. Veselovsky, Polina Yu. Zoruk, Artem B. Ivanov, Maya V. Odorskaya, Severina D. Koldman, Vail A. Koldman, Ksenia M. Klimina

Genes & Cells · 06.03.2026 · 21 (1) · 33-51

DOI: 10.17816/gc678874 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes & Cells, online erschienen am 06.03.2026. Verfasst von Evgenii I. Olekhnovich und 10 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Probiotics are capable of modulating immune responses through interactions with the gut microbiota, potentially enhancing the efficacy of immunotherapy and reducing adverse effects of chemotherapy and radiotherapy. Certain probiotic strains have demonstrated the ability to suppress chronic inflammation and augment antitumor immunity; however, their clinical application requires further investigation. AIM: This work aimed to evaluate the effects of oral administration of the probiotic strains Lacticaseibacillus rhamnosus K32 and Bifidobacterium adolescentis 150 on tumor growth and gene expression in the B16-F10 melanoma model, as well as on gut microbiota composition in experimental animals. METHODS: The experiment was conducted in C57BL/6 mice bearing B16-F10 melanoma. Animals were divided into three groups: control (no intervention) and two experimental groups for oral administration of B. adolescentis 150 or L. rhamnosus K32, respectively. Changes in gut microbiota composition were analyzed by full-length 16S rRNA gene sequencing using Oxford Nanopore technology. The transcriptomic response of B16-F10 melanoma cells to probiotic administration was assessed by RNA sequencing. RESULTS: Substantial differences were observed in the effects of the studied probiotic strains on B16-F10 melanoma progression. B. adolescentis 150 significantly stimulated experimental tumor growth by 29% (padj. = 0.02 vs. control; padj. = 0.001 vs. L. rhamnosus K32; adj., Bonferroni correction applied). At the molecular level, this stimulation was associated with suppression of interferon signaling, activation of proliferative pathways (WNT/β-catenin, TGF-β), and reduced expression of immune cell markers in melanoma tissue. In contrast, L. rhamnosus K32 reduced tumor growth by 18% (not significant; padj. = 0.4) and was associated with increased expression of cytotoxic T lymphocyte and NK cell markers, as well as activation of interferon response pathways. Both probiotic strains induced marked alterations in gut microbiota composition, characterized by an increased relative abundance of Klebsiella spp., and were associated with activation of proinflammatory signaling pathways (NF-κB, IL-6/JAK/STAT3, IL-2/STAT5) in tumor tissue. Notably, administration of both probiotics was linked to activation of epithelial–mesenchymal transition and hypoxia in the tumor, potentially creating conditions favorable for tumor progression and metastasis. CONCLUSION: These findings highlight the complex and context-dependent effects of probiotics on tumor development and underscore the need for careful strain selection in the adjuvant therapy of melanoma and other malignancies.

Zitieren

APA

Olekhnovich, E. I., Strokach, A. A., Kanaeva, V. A., Morozov, M. D., Veselovsky, V. A., Zoruk, P. Y., Ivanov, A. B., Odorskaya, M. V., Koldman, S. D., Koldman, V. A., & Klimina, K. M. (2026). Proliferative and transcriptomic response of experimental B16-F10 melanoma to modulation of murine microbiota by oral administration of Lacticaseibacillus rhamnosus K32 and Bifidobacterium adolescentis 150. Genes & Cells, 21(1), 33-51. https://doi.org/10.17816/gc678874

Vancouver

Olekhnovich EI, Strokach AA, Kanaeva VA, Morozov MD, Veselovsky VA, Zoruk PY, et al. Proliferative and transcriptomic response of experimental B16-F10 melanoma to modulation of murine microbiota by oral administration of Lacticaseibacillus rhamnosus K32 and Bifidobacterium adolescentis 150. Genes & Cells. 2026;21(1):33-51. doi:10.17816/gc678874

BibTeX
@article{Olekhnovich2026,
  author = {Olekhnovich, Evgenii I. and Strokach, Alexandra A. and Kanaeva, Vera A. and Morozov, Maxim D. and Veselovsky, Vladimir A. and Zoruk, Polina Yu. and Ivanov, Artem B. and Odorskaya, Maya V. and Koldman, Severina D. and Koldman, Vail A. and Klimina, Ksenia M.},
  title = {Proliferative and transcriptomic response of experimental B16-F10 melanoma to modulation of murine microbiota by oral administration of Lacticaseibacillus rhamnosus K32 and Bifidobacterium adolescentis 150},
  journal = {Genes & Cells},
  year = {2026},
  volume = {21},
  number = {1},
  pages = {33--51},
  doi = {10.17816/gc678874}
}
Kostenlos starten →